NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 53 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | -63.2% | 82,199 | -0.4% | 0.00% | – |
| Q2 2022 | $87,000 | -43.9% | 82,499 | +0.4% | 0.00% | – |
| Q1 2022 | $155,000 | -33.2% | 82,199 | -0.2% | 0.00% | – |
| Q4 2021 | $232,000 | -38.6% | 82,391 | -21.4% | 0.00% | – |
| Q3 2021 | $378,000 | -28.0% | 104,796 | -4.5% | 0.00% | – |
| Q2 2021 | $525,000 | -31.8% | 109,685 | +5.2% | 0.00% | – |
| Q1 2021 | $770,000 | +23.2% | 104,235 | +16.6% | 0.00% | – |
| Q4 2020 | $625,000 | -5.0% | 89,371 | +3.1% | 0.00% | – |
| Q3 2020 | $658,000 | +439.3% | 86,724 | +523.9% | 0.00% | – |
| Q2 2020 | $122,000 | – | 13,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |